|
|||||
|
|
| Rationale and Design of the IROCAS Study: Multicenter,International, Randomized Phase 3 Trial Comparing Adjuvant Modified (m) FOLFIRINOX to mFOLFOX6 in Patients With High-Risk Stage III (pT4 and/or N2) Colon Cancer—A UNICANCER GI-PRODIGE Trial | |
| 摘 要： | |
| 收稿时间： | 2018-05-29 |
| 本文献已被 ScienceDirect 等数据库收录！ | |